Morgan Stanley Maintains Overweight Rating for Clarivate: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Clarivate CLVT and lower its price target from $16.00 to $15.00.

Shares of Clarivate are trading down 2.75% over the last 24 hours, at $11.86 per share.

A move to $15.00 would account for a 26.53% increase from the current share price.

About Clarivate

Clarivate PLC is an information service and analytics company serving the scientific research, intellectual property, and life sciences end-markets. It operates in two segments: Science and Intellectual Property(IP). The Science segment provides structured information that is delivered and embedded into the workflows of the company's customers. The IP segment help and manage customers an end-to-end portfolio of intellectual property from patents to trademarks to corporate website domains. The company's brand portfolio includes Web of Science, Derwent, Cortellis, DRG, CompuMark, MarkMonitor, and CPA Global. Its geographical segments are the Americas, Europe/Middle East/Africa, and Asia-Pacific.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.